Enroll in Research > Research Search & Enroll Tool > A National Survey to Share the Voice and Treatment Preferences of Ovarian Cancer Patients
A National Survey to Share the Voice and Treatment Preferences of Ovarian Cancer Patients

A National Survey to Share the Voice and Treatment Preferences of Ovarian Cancer Patients

Surveys, Registries, Interviews

Study Contact Information:

If you are interested in participating, please contact us at: contact@global-patients.com. You can also contact our recruiters for further information: Joanna Rodriguez,

joanna@global-patients.com, +1 518 768 7995 and Noelia Perez, noelia@global-patients.com, +1 979-227-4042.


A National Survey to Share the Voice and Treatment Preferences of Ovarian Cancer Patients

About the Study

We would like to invite you to make your views heard as to the real-world burden and impact of ovarian cancer and preference for different ways of taking medication.  The research hopes to identify areas for improvement in supporting the lives of patients living with ovarian cancer and the people that care for them after 1st surgery and chemotherapy.

By taking part in the survey your views, alongside those of other patients living with ovarian cancer will be heard and help generate the scientific evidence required to ensure:

  • Your preferences are a top priority in terms of what medications are developed and made available
  • HCPs and other healthcare supporting bodies have a deep understanding about what it is like living with advanced ovarian cancer that can help provide them with the tools to support patients and their families.

What the Study Entails

The study consists of a short screening telephone call to determine your eligibility for the study. If eligible, you will be asked to complete one 25-minute-long online survey which is available in English or Spanish. After completion of the survey, you will be compensated for your time with a $50 e-Visa card or check, as a token of our appreciation.

Lead Researchers/Study PIs and Affiliation

Adelphi Real World

This Study is Open To:

Eligible study participants include any adult who is now eligible for 1st line maintenance therapy (either active surveillance only or drug treatment) following completion of 1st line treatment (surgery and chemotherapy) for ovarian cancer.

This Study is Not Open To:

People who have not been diagnosed with ovarian cancer and those who are no longer eligible for 1st line maintenance therapy